Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Haatch Ventures
Haatch EIS Fund
26th Sep 2023
Apax Global Alpha
Resilience in face of rising interest rates
25th Sep 2023
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
81: Why investor concerns over hardware are overblown | Damon Bonser of British Design Fund
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can still be accessed for free under MIFID II.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Allergy Therapeutics plc
Life Sciences
Disruptive peanut allergy vaccine
By
Dr Martin Hall
13 Feb 2017
R.E.A. Holdings
Agriculture
Fixed Interest Investments
By
Yingheng Chen
06 Feb 2017
Stay up-to-date with the latest research
Sign up to our newsletter
Morses Club Plc
Financials
Initiation: Bringing Home Collect into the 21st Century
By
Mark Thomas
02 Feb 2017
Alliance Pharma Plc
Life Sciences
Potential of Diclectin
By
Dr Martin Hall
25 Jan 2017
City of London Investment Group
Financials
Q2 statement shows robust profitability
By
Dr Brian Moretta
24 Jan 2017
Allergy Therapeutics plc
Life Sciences
Investment driving market share gains
By
Dr Martin Hall
20 Jan 2017
Diurnal Group Plc
Life Sciences
Infacort® – On track to market
By
Dr Martin Hall
19 Jan 2017
City of London Investment Group
Financials
Swings and roundabouts
By
Dr Brian Moretta
06 Jan 2017
Non-Standard Finance
Financials
“Carpe Diem”
By
Mark Thomas
11 Nov 2016
Prev
1
...
68
69
70
